The Filing Desk

Ceribell vs IRADIMED

Ceribell CBLL · IRADIMED IRMD · Health Care Equipment

Ceribell reported revenue of $89 million in fiscal 2025, about the same as IRADIMED's $84 million in fiscal 2025. Ceribell's revenue grew 36.1% in its latest year, and IRADIMED's grew 14.4%. Ceribell had an operating margin of -65.6%, against 31.2% at IRADIMED. Free cash flow was −$42 million at Ceribell and $17 million at IRADIMED.

Side by side

CeribellIRADIMED
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$89M$84M
Revenue growth36.1%14.4%
Revenue growth a year, last 5 years—21.5%
Gross margin87.9%76.8%
Operating margin−65.6%31.2%
Net margin−60.0%26.8%
Free cash flow−$42M$17M
Free cash flow margin−46.7%20.5%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$15M
Change in diluted share count205.8%0.6%
Last close$26.14$85.35
P/E at the last close—45.6×
Insider trades, last 12 months——
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CeribellIRADIMED
Operating margin
Percent of revenue
CeribellIRADIMED
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CeribellIRADIMED

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Ceribell and IRADIMED pages.